Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BSGM BioSig Technologies, Inc. Appoints Donald E. Foley to Its Board of Directors
Accomplished Finance and Institutional Money Management CEO to Join Independent Board and Add Significant Capital Markets, Strategy, and Policy Experience
BSGM BioSig Technologies, Inc. Appoints Donald E. Foley to Its Board of Directors
Accomplished Finance and Institutional Money Management CEO to Join Independent Board and Add Significant Capital Markets, Strategy, and Policy Experience
$BSGM ~ Great News Out ~ About BioSig Technologies
BioSig Technologies is a medical device company that is developing a proprietary technology platform designed to improve the $3 billion electrophysiology (EP) marketplace(1) (www.biosigtech.com). Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP System.
PURE EP System is a surface electrocardiogram and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used to guide the EPs in identifying ablation targets -- areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia).
Analysts forecast the global market for EP devices will grow at a 12.1 percent compound annual growth rate, from $2.5 billion in 2012 to $5.5 billion by 2019(1) -- making it one of the fastest growing medical device segments. Just in the US, the number of Atrial Fibrillation (AF) and Ventricular Tachycardia (VT) arrhythmia ablations is forecast to grow at 10.5 percent from 2012 to 2017(2).
BioSig intends to seek FDA 510(k) clearance for the PURE EP System. The Company has achieved proof of concept validation through UCLA labs, and has performed preclinical studies at the Mayo Clinic in Minnesota. The Company is collaborating with several of the nation's most prestigious cardiac arrhythmia centers including Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, and Mayo Clinic.
(1) Electrophysiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
(2) HRI 2013 "Global Opportunities in Medical Devices & Diagnostics" report; triangulation of multiple sources; *AF includes left atrial tachycardia, left WPW, left atrial flutter.
Contact:
Investor Relations
Brian McLaughlin
BioSig Technologies, Inc.
bmclaughlin@biosigtech.com
917-370-9817
http://finance.yahoo.com/news/biosig-technologies-inc-appoints-donald-120000281.html
$BSGM ~ Great News Out ~ About BioSig Technologies
BioSig Technologies is a medical device company that is developing a proprietary technology platform designed to improve the $3 billion electrophysiology (EP) marketplace(1) (www.biosigtech.com). Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP System.
PURE EP System is a surface electrocardiogram and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used to guide the EPs in identifying ablation targets -- areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia).
Analysts forecast the global market for EP devices will grow at a 12.1 percent compound annual growth rate, from $2.5 billion in 2012 to $5.5 billion by 2019(1) -- making it one of the fastest growing medical device segments. Just in the US, the number of Atrial Fibrillation (AF) and Ventricular Tachycardia (VT) arrhythmia ablations is forecast to grow at 10.5 percent from 2012 to 2017(2).
BioSig intends to seek FDA 510(k) clearance for the PURE EP System. The Company has achieved proof of concept validation through UCLA labs, and has performed preclinical studies at the Mayo Clinic in Minnesota. The Company is collaborating with several of the nation's most prestigious cardiac arrhythmia centers including Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, and Mayo Clinic.
(1) Electrophysiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
(2) HRI 2013 "Global Opportunities in Medical Devices & Diagnostics" report; triangulation of multiple sources; *AF includes left atrial tachycardia, left WPW, left atrial flutter.
Contact:
Investor Relations
Brian McLaughlin
BioSig Technologies, Inc.
bmclaughlin@biosigtech.com
917-370-9817
http://finance.yahoo.com/news/biosig-technologies-inc-appoints-donald-120000281.html
$BSGM Board of Directors - http://biosigtech.com/about-us/board-of-directors/
$BSGM Board of Directors - http://biosigtech.com/about-us/board-of-directors/
BSGM Mr. Foley was elected chief executive officer and chairman of Wilmington Trust in June and July 2010. He joined the Board of Directors in July 2006.
BSGM Mr. Foley was elected chief executive officer and chairman of Wilmington Trust in June and July 2010. He joined the Board of Directors in July 2006.
$EPAZ Services offered by Epazz, Inc.
http://www.epazz.com/Services.aspx
Epazz provides all of the services needed for you and your team to make your BoxesOS installation a success. We will help integrate all of your back-end systems. Our programmers will develop custom applications to make sure your business is fully web enable.
$EPAZ Services offered by Epazz, Inc.
http://www.epazz.com/Services.aspx
Epazz provides all of the services needed for you and your team to make your BoxesOS installation a success. We will help integrate all of your back-end systems. Our programmers will develop custom applications to make sure your business is fully web enable.
$EPAZ Contact Info
205 W. Wacker Drive.
Suite 1320
Chicago, IL 60606
Website: http://www.epazz.com
Phone: (312) 955-8161
$EPAZ Contact Info
205 W. Wacker Drive.
Suite 1320
Chicago, IL 60606
Website: http://www.epazz.com
Phone: (312) 955-8161
$EPAZ Trader's Cheat Sheet:
http://www.barchart.com/cheatsheet.php?sym=EPAZ
$EPAZ Trader's Cheat Sheet:
http://www.barchart.com/cheatsheet.php?sym=EPAZ
$EPAZ getting some action
EPAZ getting some action
$EPAZ Technical Analysis:
http://www.barchart.com/technicals/stocks/EPAZ
$EPAZ Technical Analysis:
http://www.barchart.com/technicals/stocks/EPAZ
$EPAZ Launches $1 Million Revenue Share Crowdfunding Campaign With the Goal of Attracting Angel Investing Online to Its Investment Opportunities ~ http://finance.yahoo.com/news/epazz-launches-1-million-revenue-121500858.html
$EPAZ Launches $1 Million Revenue Share Crowdfunding Campaign With the Goal of Attracting Angel Investing Online to Its Investment Opportunities ~ http://finance.yahoo.com/news/epazz-launches-1-million-revenue-121500858.html
$EPAZ recent news!
Bloomberg: http://www.bloomberg.com/quote/EPAZ:US
Morningstar: http://quotes.morningstar.com/stock/s?t=EPAZ
Businessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=EPAZ
$EPAZ recent news!
Bloomberg: http://www.bloomberg.com/quote/EPAZ:US
Morningstar: http://quotes.morningstar.com/stock/s?t=EPAZ
Businessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=EPAZ
EPAZ Epazz Revenue-Based Crowdfunding Campaign Will Be Under Reg 506(c) and Is Non-Dilutive to Shareholders:
http://finance.yahoo.com/news/epazz-revenue-based-crowdfunding-campaign-121500392.html
EPAZ Epazz Revenue-Based Crowdfunding Campaign Will Be Under Reg 506(c) and Is Non-Dilutive to Shareholders:
http://finance.yahoo.com/news/epazz-revenue-based-crowdfunding-campaign-121500392.html
$EPAZ is demonstrating substantial growth in a competitive industry; Overall Company Growth of over 300% in last 3 years.
$EPAZ is demonstrating substantial growth in a competitive industry; Overall Company Growth of over 300% in last 3 years.
Recent Headlines for $EPAZ
http://finance.yahoo.com/q/h?s=EPAZ&ql=1
Recent Headlines for $EPAZ
http://finance.yahoo.com/q/h?s=EPAZ&ql=1
$EPAZ BarChart Trader's Cheat Sheet
http://www.barchart.com/cheatsheet.php?sym=EPAZ
$EPAZ BarChart Trader's Cheat Sheet
http://www.barchart.com/cheatsheet.php?sym=EPAZ
Trend Analysis for $EPAZ
http://www.stockta.com/cgi-bin/analysis.pl?symb=EPAZ&mode=table&table=trend
Trend Analysis for $EPAZ
http://www.stockta.com/cgi-bin/analysis.pl?symb=EPAZ&mode=table&table=trend
$EPAZ Is Installing Over $50,000 Worth of Contracts for Its SystemVIEW Cloud Product
http://finance.yahoo.com/news/epazz-installing-over-50-000-130000062.html
$EPAZ Is Installing Over $50,000 Worth of Contracts for Its SystemVIEW Cloud Product
http://finance.yahoo.com/news/epazz-installing-over-50-000-130000062.html
Check this out $EPAZ ~~~~ http://revenuesharecrowdfunding.com/
Check this out $EPAZ ~~~~ http://revenuesharecrowdfunding.com/
$EPAZ Is Installing Over $50,000 Worth of Contracts for Its SystemVIEW Cloud Product
http://finance.yahoo.com/news/epazz-installing-over-50-000-130000062.html
$EPAZ Is Installing Over $50,000 Worth of Contracts for Its SystemVIEW Cloud Product
http://finance.yahoo.com/news/epazz-installing-over-50-000-130000062.html